Skip to main content

Advertisement

SpringerLink
Log in

Moraxella catarrhalis: Clinical significance, antimicrobial susceptibility and BRO beta-lactamases

  • Review
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Moraxella catarrhalis is an important pathogen of humans. It is a common cause of respiratory infections, particularly otitis media in children and lower respiratory tract infections in the elderly. Colonisation of the upper respiratory tract appears to be associated with infection in many cases, although this association is not well understood. Nosocomial transmission is being increasingly documented and the emergence of this organism as a cause of bacteremia is of concern. The widespread production of aβ-lactamase enzyme rendersMoraxella catarrhalis resistant to the penicillins. Cephalosporins andβ-lactamase inhibitor combinations are effective for treatment ofβ-lactamase producers, and the organism remains nearly universally susceptible to the macrolides, fluoroquinolones, tetracyclines and the combination of trimethoprim and sulfamethoxazole. Two majorβ-lactamase forms, BRO-1 and BRO-2, have been described on the basis of their isoelectric focusing patterns. The BRO-1 enzyme is found in the majority ofβ-lactamase-producing isolates and confers a higher level of resistance to strains than BRO-2. The BRO enzymes are membrane associated and their production appears to be mediated by chromosomal determinants which are transmissible by an unknown mechanism. The origin of these novel proteins is unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pfister LE, Gallagher MV, Potterfield TG, Brown DW:Neisseria catarrhalis bacteremia with meningitis. Journal of the American Medical Association (1965) 193:399–401

    PubMed  Google Scholar 

  2. Vaneechoutte M, Verschraegen G, Claeys G, Weise B, Van Den Abeele AM: Respiratory tract carrier rates ofMoraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation ofMoraxella catarrhalis from sputum. Journal of Clinical Microbiology (1990) 28:2674–2680

    PubMed  Google Scholar 

  3. Murphy TF:Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiological Reviews (1996) 60:267–279

    PubMed  Google Scholar 

  4. Murphy TF, Sethi S: Bacterial infection in chronic obstructive pulmonary disease. American Review of Respiratory Disease (1992) 146:1067–1083

    PubMed  Google Scholar 

  5. McLeod DT, Ahmad F, Capewell S, Croughan MJ, Calder MA, Seaton A: Increase in bronchopulmonary infection due toBranhamella catarrhalis. British Medical Journal (1986) 292:1103–1105

    PubMed  Google Scholar 

  6. Nicotra B, Rivera M, Luman JI, Wallace RJ:Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Archives of Internal Medicine (1986) 146:890–893

    PubMed  Google Scholar 

  7. Ninane G, Joly J, Kraytman M: Bronchopulmonary infection due toBranhamella catarrhalis: 11 cases assessed by transtracheal puncture. British Medical Journal (1978) i:276–278

    Google Scholar 

  8. Aitken JM, Thornley PE: Isolation ofBranhamella catarrhalis from sputum and tracheal aspirate. Journal of Clinical Microbiology (1983) 18:1262–1263

    PubMed  Google Scholar 

  9. Hager H, Verghese A, Alvarez S, Berk SL:Branhamella catarrhalis respiratory infections. Reviews of Infectious Diseases (1987) 9:1140–1149

    PubMed  Google Scholar 

  10. Darelid J, Lofgren S, Malmvall BE: Erythromycin treatment is beneficial for longstandingMoraxella catarrhalis associated cough in children. Scandinavian Journal of Infectious Diseases (1993) 25:323–329

    PubMed  Google Scholar 

  11. Choo PW, Gantz NM:Branhamella catarrhalis pneumonia with bacteremia. Southern Medical Journal (1989) 82:1317–1318

    PubMed  Google Scholar 

  12. Wallace MR, Oldfield EC:Moraxella (Branhamella) catarrhalis bacteremia. Archives of Internal Medicine (1990) 150:1332–1334

    PubMed  Google Scholar 

  13. Collazos J, de Miguel J, Ayarze R:Moraxella catarrhalis bacteremic pneumonia in adults; two cases and review of the literature. European Journal of Clinical Microbiology & Infectious Diseases (1992) 11:237–240

    Google Scholar 

  14. Chapman AJ, Musher DM, Jonsson S, Calridge JE, Wallace RJ: Development of bactericidal antibody duringBranhamella catarrhalis infection. Journal of Infectious Diseases (1985) 151:878–882

    PubMed  Google Scholar 

  15. Shurin PA, Marchant CD, Kim CH, Van Hare GF, Johnson CE, Tutihasi MA, Knapp LJ: Emergence of beta-lactamase producing strains ofBranhamella catarrhalis as important agents of acute otitis media. Pediatric Infectious Disease Journal (1983) 2:34–38

    Google Scholar 

  16. Calder MA, Croughan MJ, McLeod DT, Ahmad F: The incidence and antibiotic susceptibility ofBranhamella catarrhalis in respiratory infections. Drugs (1986) 31, Supplement 3:11–16

    Google Scholar 

  17. Davies BI, Maesen FPV: The epidemiology of respiratory tract pathogens in Southern Netherlands. European Respiratory Journal (1988) 1:415–420

    PubMed  Google Scholar 

  18. Wright PW, Wallace RJ, Shepherd JR: A descriptive study of 42 cases ofBranhamella catarrhalis pneumonia. American Journal of Medicine (1990) 88, Supplement 5A:2–8

    Google Scholar 

  19. Chong CY, Lim WH, Heng JT, Chay OM: The changing trend in the pattern of infective etiologies in childhood acute lower respiratory tract infection. Acta Paediatrica Japonica (1997) 39:317–321

    PubMed  Google Scholar 

  20. Henriksen SD:Moraxella, Neisseria, Branhamella andAcinetobacter. Annual Reviews of Microbiology (1976) 30:63–83

    Google Scholar 

  21. Blackwell C, Young H, Bain S: Isolation ofNeisseria meningitidis andNeisseria catarrhalis from the genitourinary tract and anal canal. British Journal of Venereal Disease (1978) 54:41–44

    Google Scholar 

  22. Wilhelmus KR, Peacock J, Coster DJ:Branhamella keratitis. British Journal of Ophthalmology (1980) 64:892–895

    PubMed  Google Scholar 

  23. Ingvarsson L, Lundgren K, Ursing J: The bacterial flora in the nasopharynx in healthy children. Acta Otolaryngology (1982) 386, Supplement:94–96

    Google Scholar 

  24. Aniansson G, Alm B, Andersson B, Larsson P, Nylen O, Peterson H, Rigner P, Svanborg M, Svanborg C: Nasopharyngeal colonization during the first year of life. Journal of Infectious Diseases (1992) 165, Supplement 1:38–42

    Google Scholar 

  25. Ejlertsen T, Thisted E, Ebbesen F, Olesen B, Renneberg J:Branhamella catarrhalis children and adults. A study of prevalence, time of colonisation and association with upper and lower respiratory tract infections. Journal of Infection (1994) 29:23–31

    PubMed  Google Scholar 

  26. Faden H, Harabuchi Y, Hong JJ: Epidemiology ofMoraxella catarrhalis in children during the first two years of life: relationship to otitis media. Journal of Infectious Diseases (1994) 169:1312–1317

    PubMed  Google Scholar 

  27. Ejlertsen T, Thisted E, Ostergaard PA, Renneberg J: Maternal antibodies and acquired serological response toMoraxella catarrhalis in children determined by an enzyme-linked immunosorbent assay. Clinical and Diagnostic Laboratory Immunology (1994) 1:464–468

    PubMed  Google Scholar 

  28. Pollard JA, Wallace RJ, Nash DR, Luman JI, Wilson RW: Incidence ofBranhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs (1986) 31, Supplement 3:103–108

    PubMed  Google Scholar 

  29. DiGiovanni C, Riley TV, Hoyne GF, Yeo R, Cooksey P: Respiratory tract infections due toBranhamella catarrhalis: epidemiological data from Western Australia. Epidemiology and Infection (1987) 99:445–453

    PubMed  Google Scholar 

  30. Ejlertsen T: Pharyngeal carriage ofMoraxella (Branhamella) catarrhalis in healthy adults. European Journal of Clinical Microbiology & Infectious Diseases (1991) 10:89

    Google Scholar 

  31. Klingman KL, Pye A, Murphy TF, Hill SL: Dynamics of respiratory tract colonization byBranhamella catarrhalis in bronchiectasis. American Journal of Respiratory and Critical Care Medicine (1995) 152:1072–1078

    PubMed  Google Scholar 

  32. Van Hare GF, Shurin PA, Marchant CD, Cartelli NA, Johnson CE, Fulton D, Carlin S, Kim CH: Acute otitis media caused byBranhamella catarrhalis: biology and therapy. Reviews of Infectious Diseases (1987) 9:16–27

    PubMed  Google Scholar 

  33. Felmingham D, Gruneberg RN, The Alexander Project Group: A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992–1993: The Alexander Project. Journal of Antimicrobial Chemotherapy (1996) 38, Supplement A:1–57

    Google Scholar 

  34. West M, Berk SL, Smith JK:Branhamella catarrhalis pneumonia. Southern Medical Journal (1982) 75:1021–1023

    PubMed  Google Scholar 

  35. Wallace RJ, Musher DM: In honor of Dr. Sarah Branham, a star is born. The realization ofBranhamella catarrhalis as a respiratory pathogen. Chest (1986) 90:447–450

    PubMed  Google Scholar 

  36. Bodkin S, Warde D:Moraxella catarrhalis — an unusual pathogen in bacterial tracheitis. British Medical Journal (1993) 86:208–209

    Google Scholar 

  37. Schalen L, Christensen P, Kamme C, Miorner H, Pettersson KI, Schalen C: High isolation rate ofBranhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scandinavian Journal of Infectious Diseases (1980) 12:277–280

    PubMed  Google Scholar 

  38. Hol C, Schalen C, Verduin CM, Van Dijke EEM, Verhoef J, Fleer A, Van Dijk H:Moraxella catarrhalis in acute laryngitis: infection or colonization? Journal of Infectious Diseases (1996) 174:636–638

    PubMed  Google Scholar 

  39. Brorson JE, Axelsson A, Holm SE: Studies onBranhamella catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scandinavian Journal of Infectious Diseases (1976) 8:151–155

    PubMed  Google Scholar 

  40. Wald ER, Milmore GJ, Bowen AD, Ledesma-Medina J, Salamon N, Bluestone CD: Acute maxillary sinusitis in children. New England Journal of Medicine (1981) 304:749–754

    PubMed  Google Scholar 

  41. Wald ER, Reilly JS, Casselbrant M, Ledesma-Medina J, Milmoe GJ, Bluestone CD, Chiponis D: Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor. Journal of Pediatrics (1984) 104:297–302

    PubMed  Google Scholar 

  42. Goldenhersh MJ, Rachelefsky GS, Dudley J, Brill J, Katz RM, Rohr AS, Spector SL, Siegel SC, Summanen P, Baron EJ, Finegold S: The microbiology of chronic sinus disease in children with respiratory allergy. Journal of Allergy and Clinical Immunology (1990) 85:1030–1039

    PubMed  Google Scholar 

  43. Penttila M, Savolainen S, Kiukaanniemi H, Forsblom B, Jousimiessomer H: Bacterial findings in acute maxillary sinusitis — European study. Acta Oto-Laryngologica (1997) Supplement 529:165–168

    Google Scholar 

  44. Brorson J, Malmvall B:Branhamella catarrhalis and other bacteria in the nasopharynx of children with long standing cough. Scandinavian Journal of Infectious Diseases (1981) 13:111–113

    PubMed  Google Scholar 

  45. Gottfarb P, Brauner A: Children with persistent cough — outcome with treatment and role ofMoraxella catanhalis? Scandinavian Journal of Infectious Diseases (1994) 26:545–551

    PubMed  Google Scholar 

  46. Tinkelman DG, Silk HJ: Clinical and bacteriologic features of chronic sinusitis in children. American Journal of Diseases of Children (1989) 143:938–941

    PubMed  Google Scholar 

  47. Slevin NJ, Aitken J, Thornley PE: Clinical and microbiological features ofBranhamella catarrhalis bronchopulmonary infections. Lancet (1984) i:782–783

    Google Scholar 

  48. Capewell S, McLeod DT, Croughan MJ, Ahmad F, Calder MA, Seaton A: Pneumonia due toBranhamella catarrhalis. Thorax (1988) 43:929–930

    PubMed  Google Scholar 

  49. Barreiro B, Esteban L, Prats E, Verdaguer E, Dorca J, Manresa F:Branhamella catarrhalis respiratory infections. European Respiratory Journal (1992) 5:675–679

    PubMed  Google Scholar 

  50. Chin NK, Kumarasinghe G, Lim TK:Moraxella catarrhalis respiratory infection in adults. Singapore Medical Journal (1993) 34:409–411

    PubMed  Google Scholar 

  51. Arola M, Ruuskanen O, Ziegler T, Mertsola J, Nanto-Salonen K, Putto-Laurila A, Viljanen MK, Halonen P: Clinical role of respiratory virus infection in acute otitis media. Pediatrics (1990) 86:848–855

    PubMed  Google Scholar 

  52. McNeely DJ, Kitchens CS, Kluge RM: FatalBranhamella (Neisseria) catarrhalis pneumonia in an immunodeficient host. American Review of Respiratory Disease (1976) 114:399–402

    PubMed  Google Scholar 

  53. Diamond LA, Lorber B:Branhamella catarrhalis pneumonia and immunoglobulin abnormalities: a new association? American Review of Respiratory Disease (1984) 129:876–878

    PubMed  Google Scholar 

  54. Davies BI, Maesen FPV: Treatment ofBranhamella catarrhalis infections. Journal of Antimicrobial Chemotherapy (1990) 25:1–7

    Google Scholar 

  55. Boyle FM, Georghiou PR, Tilse MH, McCormack JG:Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Medical Journal of Australia (1991) 154:592–596

    PubMed  Google Scholar 

  56. Catlin B:Branhamella catarrhalis: an organism gaining respect as a pathogen. Clinical Microbiology Reviews. (1990) 3:293–320

    PubMed  Google Scholar 

  57. Carr B, Walsh JB, Coakley D, Scott T, Mulvihill E, Keane C: Effect of age on adherence ofBranhamella catarrhalis to buccal epithelial cells. Gerontology (1989) 35:127–129

    PubMed  Google Scholar 

  58. Murphy S, Fitzgerald M, Mulcahy R, Keane C, Coakley D, Scott T: Studies on haemagglutination and serum resistance status of strains ofMoraxella catarrhalis isolated from the elderly. Gerontology (1997) 43:277–282

    PubMed  Google Scholar 

  59. Mannion PT: Sputum microbiology in a district general hospital. The role ofBranhamella catarrhalis. British Journal of Diseases of the Chest (1987) 81:391–396

    PubMed  Google Scholar 

  60. Ohlsson A, Bailey T: Neonatal pneumonia caused byBranhamella catarrhalis. Scandinavian Journal of Infectious Diseases (1985) 17:225–228

    PubMed  Google Scholar 

  61. Haddad J, Faou AL, Simconi U, Messer J: Hospital-acquired bronchopulmonary infection in premature infants due toBranhamella catarrhalis. Journal of Hospital Infection (1986) 7:301–302

    PubMed  Google Scholar 

  62. Berg RA, Bartley DL: Pneumonia associated withBranhamella catarrhalis in infants. Pediatric Infectious Disease Journal (1987) 6:569–573

    PubMed  Google Scholar 

  63. Dyson C, Poonyth HD, Watkinson M, Rose SJ: Life threateningBranhamella catarrhalis pneumonia in young infants. Journal of Infection (1990) 21:305–307

    PubMed  Google Scholar 

  64. Korppi M, Katila ML, Jaaskelainen J, Leinonen M: Role ofMoraxella (Branhamella) catarrhalis as a respiratory pathogen in children. Acta Paediatrica (1992) 81:993–996

    PubMed  Google Scholar 

  65. Berner R, Schumacher RF, Brandis M, Forster J: Colonization and infection withMoraxella catarrhalis in childhood. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:506–509

    Google Scholar 

  66. Seddon PC, Sunderland D, O'Halloran SM, Hart CA, Heaf DP:Branhamella catarrhalis colonization in preschool asthmatics. Pediatric Pulmonology (1992) 13:133–135

    PubMed  Google Scholar 

  67. Devalia JL, Grady D, Harmanyeri Y, Tabaqchali S, Davies RJ: Histamine synthesis by respiratory tract microorganisms: a possible role in pathogenicity. Journal of Clinical Pathology (1989) 42:516–522

    PubMed  Google Scholar 

  68. McLeod DT, Ahmad F, Croughan MJ, Calder MA: Bronchopulmonary infection due toB. catarrhalis: clinical features and therapeutic response. Drugs (1986) 31, Supplement 3:109–112

    Google Scholar 

  69. Sarubbi FA, Myers JW, Williams JJ, Shell CG: Respiratory infections caused byBranhamella catarrhalis. Selected epidemiologic features. American Journal of Medicine (1990) 88, Supplement 5A:5–9

    Google Scholar 

  70. Smith JMB, Lockwood BM: A 2-year survey ofBranhamella catarrhalis in a general hospital. Journal of Hospital Infection (1986) 7:277–283

    PubMed  Google Scholar 

  71. Mbaki N, Rikitome N, Nagatake T, Matsumoto K: Correlation betweenBranhamella catarrhalis adherence to oropharyngeal cells and seasonal incidence of lower respiratory tract infections. Tohoku Journal of Experimental Medicine (1987) 153:111–121

    PubMed  Google Scholar 

  72. Kovatch AL, Wald ER, Michaels RH: Beta-lactamase producingBranhamella catarrhalis causing otitis media in children. Journal of Pediatrics (1983) 102:261–264

    PubMed  Google Scholar 

  73. Bluestone CD: Otitis media and sinusitis in children. Role ofBranhamella catarrhalis. Drugs (1986) 31, Supplement 3:132–141

    Google Scholar 

  74. Faden H, Bernstein J, Stanievich J, Drystofik D, Shuff C, Hong JJ, Ogra PL: Effect of prior antibiotic treatment on middle ear disease in children. Annals of Otology, Rhinology and Laryngology (1992) 10:87–91

    Google Scholar 

  75. Aspin MM, Hoverman A, McCarty J, McLinn SE, Aronoff S, Lang DJ, Arrieta A: Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. Journal of Pediatrics (1994) 125:135–141

    Google Scholar 

  76. Faden H, Brodsky L, Waz MJ, Stanievich J, Bernstein JM, Ogra PL: Nasopharyngeal flora in the first three years of life in normal and otitis prone children. Annals of Otology, Rhinology and Laryngology (1991) 100:612–615

    Google Scholar 

  77. Stenfors LE, Raisanen S: Secretory IgA-, IgG- and C3b-coated bacteria in the nasopharynx of otitis-prone and non-otitis-prone children. Acta Otolaryngology (1993) 113:191–195

    Google Scholar 

  78. Dickinson DP, Loos BG, Dryja DM, Bernstein JM: Restriction fragment mapping ofBranhamella catarrhalis: a new tool for studying the epidemiology of this middle ear pathogen. Journal of Infectious Diseases (1988) 158:205–208

    PubMed  Google Scholar 

  79. Prellner K, Christensen P, Hoveliu B, Rosen C: Nasopharyngeal carriage of bacteria in otitis-prone and non-otitis-prone children in day-care centres. Acta Otolaryngology (1984) 98:343–350

    Google Scholar 

  80. Faden H, Duffy L, Wasielewdki R, Wolf J, Drystofik D, Tung Y: Relationship between nasopharyngeal colonization and the development of otitis media in children. Journal of Infectious Diseases (1997) 175:1440–1445

    PubMed  Google Scholar 

  81. Cook PP, Hecht DW, Snydman DR: NosocomialBranhamella catarrhalis in a paediatric intensive care unit; risk factors for disease. Journal of Hospital Infection (1989) 13:299–307

    PubMed  Google Scholar 

  82. McLeod DT, Ahmad F, Power JT, Calder MA, Seaton A: Bronchopulmonary infections due toBranhamella catarrhalis. British Medical Journal (1983) 287:1446–1447

    PubMed  Google Scholar 

  83. Patterson TF, Patterson JE, Masecar BL, Barden GE, Hierholzer WJ, Zervos MJ: A nosocomial outbreak ofBranhamella catarrhalis confirmed by restriction endonuclease analysis. Journal of Infectious Diseases (1988) 157:996–1001

    PubMed  Google Scholar 

  84. Ikram RB, Nixon M, Aitken J, Wells E: A prospective study of isolation ofMoraxella catarrhalis in a hospital during the winter months. Journal of Hospital Infection (1993) 25:7–14

    PubMed  Google Scholar 

  85. Enright MC, McKenzie H:Moraxella (Branhamella) catarrhalis — clinical and molecular aspects of a rediscovered pathogen. Journal of Medical Microbiology (1997) 46:360–371

    PubMed  Google Scholar 

  86. Ahmad F, McLeod DT, Power JT, Calder MA:Branhamella catarrhalis prevalence in a hospital population. Journal of Hospital Infection (1985) 6:71–74

    PubMed  Google Scholar 

  87. Denamur E, Suermondt G, Debroca A, Defouilloy C, Laurans G, Muir JF, Orfila J: Nosocomial pulmonary infections caused byBranhamella catarrhalis in intensive care units. Agressologie (1989) 30:251–253

    PubMed  Google Scholar 

  88. Richards SJ, Greening AP, Enright MC, Morgan MG, McKenzie H: Outbreak ofMoraxella catarrhalis in a respiratory unit. Thorax (1993) 48:91–92

    PubMed  Google Scholar 

  89. McKenzie H, Morgan MG, Jordens JZ, Enright MC, Bain M: Characterisation of hospital isolates ofMoraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. Journal of Medical Microbiology (1992) 37:70–76

    PubMed  Google Scholar 

  90. Christensen JJ, Bruun B: Bacteremia caused by a beta-lactamase producing strain ofBranhamella catarrhalis. APMIS (1985) 93:273–275

    Google Scholar 

  91. Saito H, Ananissie J, Khardori N, Bodey GP:Branhamella catarrhalis septicemia in patients with leukemia. Cancer (1988) 61:2315–2317

    PubMed  Google Scholar 

  92. Cimolai N, Adderley J:Branhamella catarrhalis bacteremia in children. Acta Pediatrica Scandanavia (1989) 78:465–468

    Google Scholar 

  93. Challier P, Vuthien H, Castaldi I: A review of four cases of bacteremia in children. Annales de Pediatrie (1990) 37:44–47

    PubMed  Google Scholar 

  94. Domingo P, Puig M, Pericas R, Mirelis B, Prats G:Moraxella catarrhalis bacteraemia in an immunocompetent adult. Scandinavian Journal of Infectious Diseases (1995) 27:95

    PubMed  Google Scholar 

  95. Ioannidis JPA, Worthington M, Greffiths JK, Snydman DR: Spectrum and significance of bacteremia due toMoraxella catarrhalis. Clinical Infectious Diseases (1995) 21:390–397

    PubMed  Google Scholar 

  96. Meyer GA, Shope TR, Waecker NJ, Lanningham FH:Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two patients and review of the literature. Clinical Pediatrics (1995) 34:146–150

    PubMed  Google Scholar 

  97. Cocchi P, Ulivelli A: Meningitis caused byNeisseria catarrhalis. Acta Pediatrica Scandanavia (1968) 57:451–453

    Google Scholar 

  98. Feign RD, San Joaqin V, Middelkamp JN: Purpura fulminans associated withNeisseria catarrhalis septicemia and meningitis. Pediatrics (1969) 44:120–123

    PubMed  Google Scholar 

  99. Doern GV, Miller MJ, Winn RE:Branhamella (Neisseria) catarrhalis systemic disease in humans, case reports and review of the literature. Archives of Internal Medicine (1981) 141:1690–1692

    PubMed  Google Scholar 

  100. Naqvi SH, Kilpatrick B, Bouhasin J:Branhamella catarrhalis meningitis following otolaryngologic surgery. APMIS (1988) Supplement 3:74–75

    Google Scholar 

  101. Daoud A, Abuekteish F, Masaadeh H: Neonatal meningitis due toMoraxella catarrhalis and review of the literature. Annals of Tropical Paediatrics (1996) 16:199–201

    PubMed  Google Scholar 

  102. Heidemann DG, Alfonso E, Forster RK, Willman S, Holland SP, Mendelson A, Miller D:Branhamella catarrhalis keratitis. American Journal of Ophthalmology (1987) 103:576–581

    PubMed  Google Scholar 

  103. Douer D, Danziger Y, Pinkhas J:Neisseria catarrhalis endocarditis. Annals of Internal Medicine (1977) 86:116

    Google Scholar 

  104. Turner HR, Taylor MR, Lockwood WR:Branhamella catarrhalis endocarditis in a patient receiving hemodialysis. Southern Medical Journal (1985) 78:1021–1022

    PubMed  Google Scholar 

  105. Craig DB, Wehrle PA:Branhamella catarrhalis septic arthritis. Journal of Rheumatology (1983) 10:985–986

    PubMed  Google Scholar 

  106. Ahmad F, McLeod DT, Croughan MJ, Calder MA: Urinary tract infection caused byBranhamella catarrhalis. Journal of Infection (1985) 10:176–177

    PubMed  Google Scholar 

  107. Smith GL:Branhamella catarrhalis infection imitating gonorrhoeae in man. New England Journal of Medicine (1987) 316:1277

    Google Scholar 

  108. Elbasnier AM, Deshpande H: Recurrent urinary tract infection with haematuria caused byMoraxella (Branhamella) catarrhalis. Journal of Infection (1993) 27:216–217

    PubMed  Google Scholar 

  109. MacArthur RD:Branhamella catarrhalis peritonitis in two continuous ambulatory peritoneal dialysis patients. Peritoneal Dialysis International (1990) 10:169–171

    PubMed  Google Scholar 

  110. Dadone C, Redaelli B:Branhamella catarrhalis peritonitis in CAPD: an avoidable complication? Peritoneal Dialysis International (1991) 11:185

    Google Scholar 

  111. Contreras MR, Ash SR, Swick SD, Grutzner J: Peritonitis due toMoraxella (Branhamella) catarrhalis in a diabetic patient receiving peritoneal dialysis. Southern Medical Journal (1993) 86:589–590

    PubMed  Google Scholar 

  112. Spark RP, Dahlberg PW, LaBelle JW: Pseudogonococcal Ophthalmia Neonatorum.Branhamella (Neisseria) catarrhalis conjunctivitis. American Journal of Clinical Pathology (1979) 72:471–473

    PubMed  Google Scholar 

  113. Garvey RJP, Reed TAG: Ophthalmia neonatorum due toBranhamella (Neisseria) catarrhalis. British Journal of Venereal Disease (1981) 57:346–347

    Google Scholar 

  114. Righter J, Nicol G:Branhamella catarrhalis conjunctivitis. Canadian Medical Association Journal (1983) 128:955–956

    PubMed  Google Scholar 

  115. Sanchez F, Navarro F, Coll P: Neonatal conjunctivitis caused byMoraxella (Branhamella) catarrhalis. Enfermedades Infecciosas Y Microbiologia Clinica (1991) 7:291

    Google Scholar 

  116. Weiss A, Brinser JH, Nazar-Stewart V: Acute conjunctivitis in childhood. Journal of Pediatrics (1993) 122:10–14

    PubMed  Google Scholar 

  117. Berk SL, Kalbfleisch JH, The Alexander Project Collaborative Group: Antibiotic susceptibility patterns of community-acquired respiratory isolates ofMoraxella catarrhalis in Western Europe and in the USA. Journal of Antimicrobial Chemotherapy (1996) 38 Supplement A:85–96

    PubMed  Google Scholar 

  118. Barber M, Waterworth PM: Antibacterial activity of the penicillins. British Medical Journal (1962) 1:1159–1163

    Google Scholar 

  119. Catlin BW: Transfer of the organism namedNeisseria catarrhalis toBranhamella gen. nov. International Journal of Systematic Bacteriology (1970) 20:155–159

    Google Scholar 

  120. Kamme C: Evaluation of the in vitro sensitivity ofNeisseria catarrhalis to antibiotics with respect to acute otitis media. Scandinavian Journal of Infectious Diseases (1970) 2:117–120

    PubMed  Google Scholar 

  121. Malmvall B, Brorsson J, Johnsson J: In vitro sensitivity of penicillin V andβ-lactamase production ofBranhamella catarrhalis. Journal of Antimicrobial Chemotherapy (1977) 3:374–375

    PubMed  Google Scholar 

  122. Ninane G, Joly J, Piot P, Kraytman M:Branhamella (Neisseria) catarrhalis as a pathogen. Lancet (1977) ii:149

    Google Scholar 

  123. Percival A, Corkill JE, Rowlands J, Sykes RB: Pathogenicity of andβ-lactamase production byBranhamella (Neisseria) catarrhalis. Lancet (1977) ii:1175

    Google Scholar 

  124. Doern GV, Brueggemann AB, Pierce G, Hogan T, Holley HP, Rauch A: Prevalence of antimicrobial resistance among 723 outpatient clinical isolates ofMoraxella catarrhalis in the Unites States in 1994 and 1995: results of a 30-centre national surveillance study. Antimicrobial Agents and Chemotherapy (1996) 40:2884–2886

    PubMed  Google Scholar 

  125. Wood G M, Johnson BC, McCormack JG:Moraxella catarrhalis: Pathogenic significance in respiratory tract infections treated by community practitioners. Clinical Infectious Diseases (1996) 22:632–636

    PubMed  Google Scholar 

  126. Farmer T, Reading C:β-lactamases ofBranhamella catarrhalis and their inhibition by clavulanic acid. Antimicrobial Agents and Chemotherapy (1982) 21:506–508

    PubMed  Google Scholar 

  127. Kallings I, Bengtsson S, Christensen P, Holm SE, Lind L, Kalin M: Antibiotic sensitivity ofHaemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes andBranhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scandinavian Journal of Infectious Diseases (1983) Supplement 39:100–105

    Google Scholar 

  128. Wallace RJ, Nash DR, Steingrube VA: Antibiotic susceptibilities and drug resistance inMoraxella (Branhamella) catarrhalis. American Journal of Medicine (1990) 88, Supplement 5A:46–50

    Google Scholar 

  129. Fung CP, Powell M, Seymour A, Yuan M, Williams JD: The antimicrobial susceptibility ofMoraxella catarrhalis isolated in England and Scotland in 1991. Journal of Antimicrobial Chemotherapy (1992) 30:47–55

    PubMed  Google Scholar 

  130. Ahmad F, McLeod DT, Croughan MJ, Calder MA: Antimicrobial susceptibility ofBranhamella catarrhalis isolates from bronchopulmonary infections. Antimicrobial Agents and Chemotherapy (1984) 26:424–425

    PubMed  Google Scholar 

  131. Doern GV, Tubert TA: In vitro activities of 39 antimicrobial agents forBranhamella catarrhalis and comparison of results with different susceptibility test methods. Antimicrobial Agents and Chemotherapy (1988) 32:259–261

    PubMed  Google Scholar 

  132. Nash DR, Flanagan C, Steele LC, Wallace RJ: Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates ofMoraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 andHaemophilus influenzas. Antimicrobial Agents and Chemotherapy (1991) 35:192–194

    PubMed  Google Scholar 

  133. Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G: In vitro activity of a new broad spectrumβ-lactamase stable oral cephalosporin cefixime, in comparison with other drugs, againstHaemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis andStreptococcus pneumoniae. Chemotherapy (1992) 38:36–45

    PubMed  Google Scholar 

  134. Felmingham D, Robbins MJ, Dencer C, Nathwani A, Grunberg RN: Antimicrobial susceptibility of community-acquired bacterial lower respiratory tract pathogens. Journal of Antimicrobial Chemotherapy (1996) 28:747–751

    Google Scholar 

  135. Luman I, Wilson RW, Wallace RJ, Nash DR: Disk diffusion susceptibility ofBranhamella catarrhalis and relationship ofβ-lactam zone size toβ-lactamase production. Antimicrobial Agents and Chemotherapy (1986) 30:774–776

    PubMed  Google Scholar 

  136. Seto WH, Yuen KY: The successful treatment ofBranhamella catarrhalis bronchopulmonary infections in adults with amoxycillin. Journal of Antimicrobial Chemotherapy (1991) 27:146–147

    PubMed  Google Scholar 

  137. Louie MH, Gabay EL, Mathison GE, Finegold SM:Branhamella catarrhalis pneumonia. Western Journal of Medicine (1983) 138:47–49

    PubMed  Google Scholar 

  138. Bogaerts J, Lepage P, Vande Weghe JP, Vandepitte J: Severe respiratory infection withBranhamella catarrhalis in an African child. European Journal of Pediatrics (1985) 143:303–304

    PubMed  Google Scholar 

  139. Ejlertsen T, Skov R: Theβ-lactamase ofMoraxella (Branhamella) catarrhalis isolated from Danish children. APMIS (1996) 104:557–562

    PubMed  Google Scholar 

  140. Motte S, Derruys E, Thys J: Therapeutic failure due toBranhamella catarrhalis in pneumococcal pneumonia. Chest (1987) 92:382–383

    PubMed  Google Scholar 

  141. Livermore DM:β-Lactamases in laboratory and clinical resistance. Clinical Microbiological Reviews (1995) 8:557–584

    Google Scholar 

  142. Doern GV, Siebers KG, Hallick LM, Morse SA: Antibiotic susceptibility of beta-lactamase producing strains ofBranhamella (Neisseria) catarrhalis. Antimicrobial Agents and Chemotherapy (1980) 17:24–29

    PubMed  Google Scholar 

  143. Farmer T, Reading C: Inhibition of theβ-lactamase ofBranhamella catarrhalis by clavulanic acid and other inhibitors. Drugs (1986) 31, Supplement 3:70–78

    PubMed  Google Scholar 

  144. Slocombe B: Inhibition ofβ-lactamases inBranhamella catarrhalis. Drugs (1986) 31, Supplement 3:79–81

    PubMed  Google Scholar 

  145. Wallace RJ, Steele LC, Brooks DL, Luman JI, Wilson RW, McLarty JW: Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positiveHaemophilus influenzae andBranhamella catarrhalis. Antimicrobial Agents and Chemotherapy (1985) 27:912–915

    PubMed  Google Scholar 

  146. Marchant CD, Shurin PA, Johnson CE, Murdell-Panek D, Feinstein JC, Fulton D, Flexon P, Carlin SA, Van Hare GF: A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. Journal of Pediatrics (1986) 109:891–896

    PubMed  Google Scholar 

  147. Wardle JK:Branhamella catarrhalis as an indirect pathogen. Drags (1986) 31, Supplement 3:93–96

    Google Scholar 

  148. Kaiser L, Lew D, Hirschel B, Auckenthaler R, Morabia A, Heald A, Benedict P, Terrier F, Wunderli W, Matter L, Germann D, Voegeli J, Stalder H: Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet (1996) 347:1507–1510

    PubMed  Google Scholar 

  149. Thornley PE, Aitken JM, Nichol GM, Slevin NJ: Amoxycillin-clavulanic acid combination in bronchopulmonary infection due toβ-lactamase producingBranhamella catarrhalis: preliminary report. Drugs (1986) 31, Supplement 3:113–114

    PubMed  Google Scholar 

  150. Robledano L, Rivera MJ, Otal I, Gomez-lus R: Enzymatic modification of aminoglycoside antibiotics byBranhamella catarrhalis carrying an R factor. Drugs under Experimental and Clinical Research (1987) 13:137–143

    PubMed  Google Scholar 

  151. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS: Antimicrobial resistance among respiratory isolates ofHaemophilus influenzae, Moraxella catarrhalis, andStreptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy (1990) 34:2075–2080

    PubMed  Google Scholar 

  152. Gotoh N, Tanaka S, Nishino T: Supersusceptibility to hydrophobic antimicrobial agents and cell surface hydrophobicity inBranhamella catarrhalis. FEMS Microbiology Letters (1989) 59:211–214

    Google Scholar 

  153. Alvarez S, Jones M, Holtsclaw-Berk S, Guarderas J, Berk SL: In vitro susceptibilities andβ-lactamase production of 53 clinical isolates ofBranhamella catarrhalis. Antimicrobial Agents and Chemotherapy (1985) 27:646–647

    PubMed  Google Scholar 

  154. Sweeney KG, Berghese A, Needham CA: In vitro susceptibilities of isolates from patients withBranhamella catarrhalis pneumonia compared with those of colonising strains. Antimicrobial Agents and Chemotherapy (1985) 27:499–502

    PubMed  Google Scholar 

  155. Brown BA, Wallace RJ, Flannagan CW, Wilson RW, Luman JI, Redditt R: Tetracycline and erythromycin resistance among clinical isolates ofBranhamella catarrhalis. Antimicrobial Agents and Chemotherapy (1989) 33:1631–1633

    PubMed  Google Scholar 

  156. Spencer RC, Wheat PF: In vitro activity of roxithromycin againstBranhamella catarrhalis. Journal of Antimicrobial Chemotherapy (1990) 26:153–154

    Google Scholar 

  157. Zheng X, Cao Y: Beta-lactamase producingBranhamella in Beijing, China. Pediatric Infectious Disease Journal (1988) 7:744

    Google Scholar 

  158. Roberts MC, Brown BA, Steingrube VA, Wallace RJ: Genetic basis of tetracycline resistance inMoraxella (Branhamella) catarrhalis. Antimicrobial Agents and Chemotherapy (1990) 34:1816–1818

    PubMed  Google Scholar 

  159. Roberts MC, Pang Y, Spencer RC, Winstanley TG, Brown BA, Wallace RJ: Tetracycline resistance inMoraxella. (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis. Antimicrobial Agents and Chemotherapy (1991) 35:2453–2455

    PubMed  Google Scholar 

  160. Gomez J, Ruiz-Gomez J, Hernandez-Cardona JL, Nunez ML, Canteras M, Valdes M: Antibiotic resistance patterns ofStreptococcus pneumoniae, Haemophilus influenzae andMoraxella catarrhalis: A prospective study in Murcia, Spain, 1983–1992. Chemotherapy (1994) 40:299–303

    PubMed  Google Scholar 

  161. Schalen L, Eliasson I, Kamme C, Schalen C: Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology and Laryngology (1993) 102:209–214

    Google Scholar 

  162. Klein NC: Fluoroquinolones in respiratory infections. Seminars in Respiratory Infection (1991) 6:131–135

    Google Scholar 

  163. Bourgeois F, Bingen E: Killing kinetics of five fluoroquinolones againstMoraxella catarrhalis at clinically achievable concentrations. Journal of Antimicrobial Chemotherapy (1994) 33:364–365

    PubMed  Google Scholar 

  164. Hoogkamp-Korstanje JAA: In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, oflxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gramnegative pathogens from respiratory tract infections. Journal of Antimicrobial Chemotherapy (1997) 40:427–431

    PubMed  Google Scholar 

  165. Forsgren A, Walder M: Antimicrobial susceptibility of bacterial isolates in South Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS (1994) 102:227–235

    PubMed  Google Scholar 

  166. Cunliffe NA, Emmanuel FXS, Thomson CJ: Lower respiratory tract infection due to ciprofloxacin resistantMoraxella catarrhalis. Journal of Antimicrobial Chemotherapy (1995) 36:273–274

    PubMed  Google Scholar 

  167. Buu Hoi-Dang Van A, Brive-Le Bouquence B, Barthelemy M, Labia R: Novelβ-lactamases fromBranhamella catarrhalis. Annals of Microbiology (1978) 129B:6–10

    Google Scholar 

  168. Simpson IN, Plested SJ: The origin and properties ofβ-lactamase satellite bands seen in isoelectric focusing. Journal of Antimicrobial Chemotherapy (1983) 12:127–131

    PubMed  Google Scholar 

  169. Kamme C, Vang M, Stahl S: Intrageneric and intergeneric transfer ofBranhamella catarrhalis beta-lactamase production. Scandinavian Journal of Infectious Diseases (1984) 16:153–155

    PubMed  Google Scholar 

  170. Wallace RJ, Vincent JR, Steingrube VA, Nash DR, Hollis DG, Flanagan C, Brown BA, Labidi A, Weaver RE: BROβ-lactamases ofBranhamella catarrhalis andMomxella subgenusMoraxella, including evidence for chromosomalβ-lactamase transfer by conjugation inB. catarrhalis, M. nonliquefaciens, andM. lacunata. Antimicrobial Agents and Chemotherapy (1989) 33:1845–1854

    PubMed  Google Scholar 

  171. Eliasson I, Kamme C: Characterization of the plasmid-mediated beta-lactamase inBranhamella catarrhalis, with special reference to substrate affinity. Journal of Antimicrobial Chemotherapy (1985) 15:139–149

    Google Scholar 

  172. Bootsma HJ, van Dijk H, Verhoef J, Fleer A, Mooi FR: Molecular characterization of the BROβ-lactamases ofMoraxella (Branhamella) catarrhalis. Antimicrobial Agents and Chemotherapy (1996) 40:966–972

    PubMed  Google Scholar 

  173. Christensen JJ, Keiding J, Schumacher H, Bruun B: Recognition of a newBranhamella catarrhalis β-lactamase — BRO-3. Journal of Antimicrobial Chemotherapy (1991) 28:774–775

    PubMed  Google Scholar 

  174. Christensen JJ, Keiding JJ, Bruun B: Antimicrobial susceptibility andβ-lactamase characterization ofBranhamella catarrhalis isolates from 1983/1984 and 1988. APMIS (1990) 98:1039–1044

    PubMed  Google Scholar 

  175. Philippon A, Riou JY, Guibourdenche M, Sotolongo F: Detection, distribution and inhibition ofBranhamella catarrhalis β-lactamase. Drugs (1986) 31, Supplement 3:64–69

    Google Scholar 

  176. Stobberingh EE, Davies BI, van Boven CPA:Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases. Journal of Antimicrobial Chemotherapy (1984) 13:55–64

    Google Scholar 

  177. Eliasson I, Kamme C, Prellner K: Beta-lactamase production in the upper respiratory tract flora. European Journal of Clinical Microbiology & Infectious Diseases (1986) 5:507–512

    Google Scholar 

  178. Fung C, Jang T, Liu C, Lau Y, Liu Y, Chuang V, Lee N: Antimicrobial susceptibility andβ-lactamase production ofMoraxella catarrhalis isolates in Taiwan. Journal of the Formos Medical Association (1996) 91:548–554

    Google Scholar 

  179. Manninen R, Huovinen P, Nissinen A, The Finnish Study Group for Antimicrobial Resistance: Increasing Antimicrobial resistance inStreptococcus pneumoniae, Haemophilus influenzae andMoraxella catarrhalis in Finland. Journal of Antimicrobial Chemotherapy (1997) 40:387–392

    PubMed  Google Scholar 

  180. Nash DR, Wallace RJ, Steingrube VA, Shurin PA: Isoelectric focusing ofβ-lactamases from sputum and middle ear isolates ofBranhamella catarrhalis recovered in the United States. Drugs (1986) 31, Supplement 3:48–54

    PubMed  Google Scholar 

  181. Eliasson I, Kamme C, Vang M, Waley SG: Characterization of cell-bound papain-solubleβ-lactamases in BRO-1 and BRO-2 producing strains ofMoraxella (Branhamella) catarrhalis andMoraxella nonliquefaciens. European Journal of Clinical Microbiology & Infectious Diseases (1992) 11:313–321

    Google Scholar 

  182. Ikeda F, Yokota Y, Mine Y, Yamada T: Characterization of BRO enzymes and beta-lactamase transfer ofMoraxella (Branhamella) catarrhalis isolated in Japan. Chemotherapy (1993) 39:88–95

    PubMed  Google Scholar 

  183. Fung C, Yeo S, Livermore DM: Susceptibility ofMoraxella catarrhalis isolates toβ-lactam antibiotics in relation toβ-lactamase pattern. Journal of Antimicrobial Chemotherapy (1994) 33:215–222

    PubMed  Google Scholar 

  184. Chaibi EB, Mugnier P, Kitzis MD, Goldstein RW, Acar JF:Branhamella catarrhalis β-lactamases and their phenotypic implication. Research in Microbiology (1995) 146:761–771

    PubMed  Google Scholar 

  185. Doern GV, Tubert TA: Effect of inoculum size on results of macrotube dilution susceptibility test withBranhamella catarrhalis. Journal of Clinical Microbiology (1987) 25:1576–1578

    PubMed  Google Scholar 

  186. Jones RN, Sommers HM: Identification and antimicrobial susceptibility testing ofBranhamella catarrhalis in United States laboratories, 1983–1985. Drugs (1986) 31, Supplement 3:34–37

    PubMed  Google Scholar 

  187. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Edition 6. NCCLS Document M100-S6. NCCLS. Villanova (1995)

    Google Scholar 

  188. Doern GV, Tubert TA: Detection ofβ-lactamase activity among clinical isolates ofBranhamella catarrhalis with six differentβ-lactamase assays. Journal of Clinical Microbiology (1987) 25:1380–1383

    PubMed  Google Scholar 

  189. Yeo SF, Livermore DM: Effect of inoculum size on the in-vitro susceptibility toβ-lactam antibiotics ofMoraxella catarrhalis isolates of differentβ-lactamase types. Journal of Medical Microbiology (1994) 40:252–255

    PubMed  Google Scholar 

  190. Roques C, Roux I, Hababi L, Federlin M, Michel G: In vitro activity of oralβ-lactams against 40β-lactamase producing strains ofBranhamella (Moraxella) catarrhalis correlated to the inoculum size. Medecine et Maladies Infectieuses (1997) 27:774–777

    Google Scholar 

  191. Thickett KJ, Winstanley TG: Multipoint microbiological assay for detecting beta-lactamase. Journal of Clinical Pathology (1991) 44:435–436

    PubMed  Google Scholar 

  192. Peiris V: Detection ofβ-lactamase production inMoraxella catarrhalis. Journal of Antimicrobial Chemotherapy (1992) 30:399

    Google Scholar 

  193. Labia R, Barthelemy M, Brive Le Bouguennec C, Buu Hoi-Dang Van A: Classification ofβ-lactamases fromBranhamella catarrhalis in relation to penicillinases produced by other bacterial species. Drugs (1986) 31, Supplement 3:40–47

    Google Scholar 

  194. Stobberingh EE, van Eck HJ, Houben AW, van Boven CPA: Analysis of the relationship between ampicillin resistance and beta-lactamase production inBranhamella catarrhalis. Drugs (1986) 31, Supplement 3:23–27

    Google Scholar 

  195. Bedenic B, Zagar Z: Increased beta-lactamase activity inBranhamella catarrhalis after exposure to amoxicillin and clavulanic acid. Journal of Chemotherapy (1994) 6:383–387

    PubMed  Google Scholar 

  196. Bush K, Jacoby GA, Medeiros AA: A functional classification scheme forβ-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy (1995) 39:1211–1233

    PubMed  Google Scholar 

  197. Yokota E, Fujii T, Sato K, Inque M, Mitsuhashi S: Purification and properties of beta-lactamase produced byBranhamella catarrhalis. Antimicrobial Agents and Chemotherapy (1986) 29:696–698

    PubMed  Google Scholar 

  198. Pollock MR: Purification and properties of penicillinases from two strains ofBacillus licheniformis: a chemical, physiochemical and physiological comparison. Biochemical Journal (1965) 94:666–675

    PubMed  Google Scholar 

  199. Livermore D: Enzymes involved in bacterial resistance toβ-lactams and other antibiotics. In: Proceedings of the Symposium on Antibiotic Resistance and Cross Resistance. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1986. Hospital Practice Publication (1987) p. 23–27

    Google Scholar 

  200. Steingrube VA, Wallace RJ, Beaulieu D: A membrane-bound precursorβ-lactamase in strains ofMoraxella catarrhalis andMoraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2β-lactamases. Journal of Antimicrobial Chemotherapy (1993) 31:237–244

    PubMed  Google Scholar 

  201. Cooper CE, Slocombe B, White AR: Effect of low concentrations of clavulanic acid on the invitro activity of amoxycillin againstβ-lactamase producingBranhamella catarrhalis andHaemophilus influenzae. Journal of Antimicrobial Chemotherapy (1990) 26:371–380

    PubMed  Google Scholar 

  202. Matthew M, Harris AM, Marshall MJ, Ross GW: The use of analytical isoelectric focusing for detection and identification ofβ-lactamases. Journal of General Microbiology (1975) 88:169–178

    PubMed  Google Scholar 

  203. Yamamoto S, Lampen LO: Purification of plasma membrane penicillinase forBacillus licheniformis 749/C and comparison with exoenzyme. Journal of Biological Chemistry (1976) 251:4095–4101

    PubMed  Google Scholar 

  204. Sykes RB, Georgopapadakou NK: Bacterial resistance toβ-lactam antibiotics: an overview. In: Salton MRJ, Shockman GD (ed): Beta-lactam antibiotics: mode of action, new developments, and future prospects. Academic Press (1981) p. 199–214

  205. Livermore DM, Chai PY, Wong AIW, Leung YK:β-lactamase ofPseudomonas pseudomallei and its contribution to antibiotic resistance. Journal of Antimicrobial Chemotherapy (1987) 20:313–321

    PubMed  Google Scholar 

  206. Foweraker JE, Hawkey PM, Heritage J, Van Landuyt HW: Novelβ-lactamase fromCapnocytophaga species. Antimicrobial Agents and Chemotherapy (1990) 34:1501–1504

    PubMed  Google Scholar 

  207. Spratt BG, Cromie KD: Penicillin-binding proteins of gram-negative bacteria. Reviews of Infectious Diseases (1988) 10:699–711

    PubMed  Google Scholar 

  208. Pluckthun A, Pfitzinger I: Membrane-boundβ-lactamase forms inEscherichia coli. Journal of Biological Chemistry (1988) 263:14315–14322

    PubMed  Google Scholar 

  209. Piot P, Roberts M, Ninane G:β-Lactamase production in commensalNeisseriacea. Lancet (1979) i:619

    Google Scholar 

  210. van Embden JDA. van Klingeren B, Dessens-Kroon M, van Wijngaarden LJ: Penicillinase-producingNeisseria gonorrhoeae in the Netherlands: Epidemiology and genetic and molecular characterization of their plasmids. Antimicrobial Agents and Chemotherapy (1980) 18:789–797

    PubMed  Google Scholar 

  211. Johnson MA, Drew WL, Roberts M:Branhamella (Neisseria) catarrhalis — a lower respiratory tract pathogen? Journal of Clinical Microbiology (1981) 13:1066–1069

    PubMed  Google Scholar 

  212. Kamme C, Vang M, Stahl S: Transfer ofβ-lactamase production inBranhamella catarrhalis. Scandinavian Journal of Infectious Diseases (1983) 15:255–256

    Google Scholar 

  213. Kamme C, Eliasson I, Knutson BK, Vang M: Plasmid-mediatedβ-lactamase inBranhamella catarrhalis. Drugs (1986) 31, Supplement 3:55–63

    PubMed  Google Scholar 

  214. Beaulieu D, Ouellette M, Bergeron MG, Roy PH: Characterization of a plasmid isolated fromBranhamella catarrhalis and detection of plasmid sequences within the genome of aBranhamella catarrhalis strain. Plasmid (1988) 20:158–162

    PubMed  Google Scholar 

  215. Schaberg DR, Zervos MJ: Intergenic and interspecies gene exchange in gram positive cocci. Antimicrobial Agents and Chemotherapy (1986) 30:817–822

    PubMed  Google Scholar 

  216. Clewell DB, Flannagan SE: The conjugative transposons of gram-positive bacteria. In: D.B. Clewell (ed.): Bacterial conjugation. Plenum Press, New York (1993) p. 369–394

    Google Scholar 

  217. Roberts MC: Characterisation of the TetM determinants in urogenital and respiratory pathogens. Antimicrobial Agents and Chemotherapy (1990) 34:476–478

    PubMed  Google Scholar 

  218. Scott JR, Churchward GG: Conjugative transposition. Annual Reviews of Microbiology (1995) 49:367–397

    Google Scholar 

  219. Macrina FL: Conjugal transfer in anaerobic bacteria. In: D.B. Clewell (ed.): Bacterial conjugation. Plenum Press, New York, (1993) p. 331–348

    Google Scholar 

  220. Catlin BW: Reciprocal genetic transformation betweenNeisseria catarrhalis andMoraxella nonliquefaciens. Journal of General Microbiology (1964) 37:369–379

    PubMed  Google Scholar 

  221. Bovre K: Studies on transformation inMoraxella and organisms assumed to be related toMoraxella. 5. Streptomycin resistance transformation between serum-liquefying, nonhaemolytic moraxellae,Moraxella bovis andMoraxella nonliquefaciens. Acta Pathologica et Microbiologica Scandinavica (1965) 65:435–449

    PubMed  Google Scholar 

  222. Dorward DW, Garon CF, Judd RC: Export and intercellular transfer of DNA via membrane blebs ofNeisseria gonorrhoea. Journal of Bacteriology (1989) 171:2499–2505

    PubMed  Google Scholar 

  223. Johnson KG, McDonald IJ, Perry MB: Studies on the cellular and free lipopolysaccharides fromBranhamella catarrhalis. Canadian Journal of Microbiology (1976) 22:460–467

    PubMed  Google Scholar 

  224. Hellio R, Guibourdenche M, Collatz E, Riou JY: The envelope structure ofBranhamella catarrhalis as studied by transmission electron microscopy. Annales de l'Institut Pasteur — Microbiology (1988) 139:515–525

    PubMed  Google Scholar 

  225. Murphy TF, Loeb MR: Isolation of the outer membrane ofBranhamella catarrhalis. Microbial Pathogenesis (1989) 6:159–174

    PubMed  Google Scholar 

  226. Molstad S, Eliasson I, Hovelius B, Kamme C, Schalen C: Beta-lactamase production in the upper respiratory tract flora in relation to antibiotic consumption: a study in children attending day nurseries. Scandinavian Journal of Infectious Diseases (1988) 20:329–334

    PubMed  Google Scholar 

  227. Molstad S, Arvidsson E, Eliasson I, Hovelius B, Kamme C, Schalen C: Production of beta-lactamase by respiratory tract bacteria in children: relationship to antibiotic use. Scandanavian Journal of Primary Health Care (1992) 10:16–20

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, The University of Western Australia, Queen Elizabeth II Medical Centre, 6009, Nedlands, Western Australia, Australia

    K. McGregor, B. J. Chang, B. J. Mee & T. V. Riley

Authors
  1. K. McGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. J. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. J. Mee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. V. Riley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGregor, K., Chang, B.J., Mee, B.J. et al. Moraxella catarrhalis: Clinical significance, antimicrobial susceptibility and BRO beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 17, 219–234 (1998). https://doi.org/10.1007/BF01699978

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01699978

Keywords

Search

Navigation